Neuberg Diagnostics and Star Imaging Join Forces to Build Maharashtra’s Largest Integrated Diagnostics Network
Neuberg Diagnostics, one of India’s fastest-growing diagnostic chains, has formed a strategic joint venture with Star Imaging, a pioneer in advanced medical imaging, to create Maharashtra’s largest integrated diagnostics network. […]
Shilpa Medicare Partners with Orion to Launch Recombinant Human Albumin in Europe
Shilpa Medicare Limited, a leading player in pharmaceuticals and biotechnology, through its wholly-owned subsidiary Shilpa Biocare Private Limited, has entered into a strategic partnership with Finland-based Orion Corporation. This collaboration […]
Archish Fertility & IVF, India’s First 100% Fully Transparent Fertility Lab, Partners with Amaha Health for Holistic Patient Support & Mental Wellbeing
Bengaluru, India – Archish Fertility & IVF, has set a new benchmark in fertility care by unveiling India’s first 100% fully transparent fertility laboratory. This groundbreaking initiative ensures patients have […]
OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status
Bangalore, India, June 10, 2025 — OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), a multi-modality specialty pharma pure-play CDMO, announced that its flagship facility in Bangalore, India, has received […]
Guttify launches India’s First Clinically-Guided At-Home Fatty Liver Management Kit – “Liver Lift”
New Delhi, 09th June 2025 – Guttify, a premium gut health brand, and the first in the country to adopt a diagnosis-first approach has launched the Liver Lift Kit, India’s […]
Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA® in India to Advance Treatment of Hematological Malignancies
Mumbai, India, June 9, 2025: Glenmark Pharmaceuticals Ltd. (Glenmark) a research-led, global pharmaceutical company, has announced the upcoming launch of zanubrutinib in India following approval by the Drugs Controller General […]
Servier India introduces ‘Ivosidenib’ (Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma
Mumbai, India, June 05, 2025 – Servier India, a subsidiary of the leading French pharmaceutical Servier Group, today announced the launch of Ivosidenib (Tibsovo®), an oral targeted therapy approved in […]
Zydus gets exclusive licensing rights for next genimmuno-oncology platforms from the US based Agenus
Ahmedabad, India, June 3, 2025 Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) today announced that it has entered into a definitive agreement with Agenus Inc. (NASDAQ: […]
Zydus to enter global biologics CDMO business Plans to acquire Agenus’ U.S. manufacturing facilities to accelerate development of innovative therapies
The acquisition will establish Zydus’ presence in fast growing global biologics CDMO space. Acquired capabilities include cutting-edge biologics development and manufacturing services to serve the needs of global innovative biotechnology […]
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
Mumbai, June 2, 2025: Ichnos Glenmark Innovation (IGI), a global, fully integrated clinical stage biotechnology company focused on developing multispecificsTM in oncology, today presented promising full dose-escalation results from its […]